Associated Papers
Genetic and clinical landscape of Chinese frontotemporal dementia: dominance of TBK1 and OPTN mutations.
Nan H et al.
Alzheimer's Research & Therapy, 2024
Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation.
Morino H et al.
Movement Disorders Clinical Practice, 2024
Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons.
Al-Dalahmah O et al.
Cell Stem Cell, 2024
Dissecting the Clinical Heterogeneity and Genotype-Phenotype Correlations of MAPT Mutations: A Systematic Review.
Villa C et al.
Frontiers in Bioscience (landmark Edition), 2024
A novel MAPT variant (E342K) as a cause of familial progressive supranuclear palsy.
Li H et al.
Frontiers in Neurology, 2024
Clinical and genetic analysis of Vietnamese patients diagnosed with early-onset Parkinson's disease.
Do MD et al.
Brain and Behavior, 2023
Genetics of frontotemporal dementia in China.
Jiang Y et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2021
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases.
Ramos EM et al.
Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2020
FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G.
Tacik P et al.
Brain Pathology (zurich, Switzerland), 2017
Closing the tau loop: the missing tau mutation.
McCarthy A et al.
Brain : a Journal of Neurology, 2015
Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation.
Di Fonzo A et al.
Neurology, 2014
Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration.
Kouri N et al.
Acta Neuropathologica, 2014
Select a paper to view details